Prime Capital Investment Advisors LLC decreased its holdings in The Clorox Company (NYSE:CLX - Free Report) by 94.3% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,714 shares of the company's stock after selling 45,240 shares during the quarter. Prime Capital Investment Advisors LLC's holdings in Clorox were worth $220,000 as of its most recent filing with the SEC.
Other large investors have also recently bought and sold shares of the company. Peoples Financial Services CORP. grew its stake in shares of Clorox by 193.9% during the 3rd quarter. Peoples Financial Services CORP. now owns 1,061 shares of the company's stock worth $86,000 after purchasing an additional 700 shares during the period. Tred Avon Family Wealth LLC increased its holdings in shares of Clorox by 45.3% in the 3rd quarter. Tred Avon Family Wealth LLC now owns 9,357 shares of the company's stock valued at $834,000 after purchasing an additional 2,919 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in shares of Clorox by 18.9% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 35,560 shares of the company's stock valued at $2,881,000 after purchasing an additional 5,659 shares during the period. Jeppson Wealth Management LLC lifted its stake in shares of Clorox by 15.1% in the third quarter. Jeppson Wealth Management LLC now owns 7,070 shares of the company's stock valued at $573,000 after purchasing an additional 930 shares during the period. Finally, CWA Asset Management Group LLC lifted its stake in shares of Clorox by 90.1% in the third quarter. CWA Asset Management Group LLC now owns 9,584 shares of the company's stock valued at $776,000 after purchasing an additional 4,543 shares during the period. Hedge funds and other institutional investors own 78.53% of the company's stock.
Clorox Trading Up 0.4%
NYSE:CLX opened at $86.78 on Tuesday. The Clorox Company has a 52-week low of $79.12 and a 52-week high of $128.90. The company has a quick ratio of 0.38, a current ratio of 0.66 and a debt-to-equity ratio of 15.80. The stock has a fifty day simple moving average of $90.49 and a 200-day simple moving average of $100.42. The company has a market capitalization of $10.50 billion, a PE ratio of 18.00, a price-to-earnings-growth ratio of 2.89 and a beta of 0.59.
Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Monday, August 3rd. The company reported $1.66 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.02. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The firm had revenue of $1.95 billion for the quarter, compared to analysts' expectations of $1.91 billion. During the same period in the prior year, the company earned $2.87 EPS. The firm's revenue was down 2.0% on a year-over-year basis. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. On average, equities research analysts expect that The Clorox Company will post 5.66 earnings per share for the current fiscal year.
Clorox Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Wednesday, October 28th will be given a $1.25 dividend. The ex-dividend date is Wednesday, October 28th. This represents a $5.00 annualized dividend and a dividend yield of 5.8%. Clorox's dividend payout ratio is currently 103.73%.
Analyst Upgrades and Downgrades
A number of analysts recently commented on the stock. TD Cowen decreased their price objective on shares of Clorox from $85.00 to $80.00 and set a "hold" rating on the stock in a report on Tuesday, October 13th. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Clorox in a report on Tuesday, October 6th. Zacks Research upgraded shares of Clorox from a "strong sell" rating to a "hold" rating in a research report on Monday, September 14th. Deutsche Bank Aktiengesellschaft reissued a "hold" rating and set a $95.00 price target on shares of Clorox in a research note on Monday, October 19th. Finally, Evercore set a $99.00 price target on Clorox in a research note on Tuesday, August 4th. Twelve analysts have rated the stock with a Hold rating and four have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Reduce" and an average price target of $93.57.
Get Our Latest Research Report on CLX
About Clorox
(
Free Report)
The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.
Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt's Bees personal care items.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.